Cetera Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$910K Buy
3,357
+2,227
+197% +$532K 0.01% 1209
2023
Q4
$267K Buy
+1,130
New +$222K ﹤0.01% 1491
2023
Q3
Sell
-966
Closed -$203K 1725
2023
Q2
$203K Buy
+966
New +$192K ﹤0.01% 1503
2023
Q1
Sell
-1,055
Closed -$230K 1664
2022
Q4
$230K Buy
+1,055
New +$230K ﹤0.01% 1374
2022
Q2
Sell
-750
Closed -$213K 1387
2022
Q1
$213K Sell
750
-230
-23% -$70.9K ﹤0.01% 1283
2021
Q4
$369K Sell
980
-515
-34% -$200K 0.01% 1017
2021
Q3
$617K Buy
1,495
+755
+102% +$314K 0.01% 799
2021
Q2
$274K Buy
740
+7
+1% +$2.34K 0.01% 1096
2021
Q1
$212K Buy
+733
New +$204K 0.01% 1123

Other funds holding CRL